CIK 0001326190 · Non-accelerated filer<br>Smaller reporting company
Altimmune, Inc.
Sign in to watch- Ticker
- ALT
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 202726770
- Phone
- 862-457-1450
- Business address
- 350 MOUNT KEMBLE AVENUE, SUITE 1001, MORRISTOWN, NJ, 07960
- Former names
- PHARMATHENE, INC, HEALTHCARE ACQUISITION CORP
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 8-K Event Shareholder vote results
- 8-K Event Regulation FD disclosure · Other events
- 4 Open-market sale President and CEO sold 20,000 shares at $20.02 ($400,322)
- DEF 14A Proxy Proxy Statement
- 4 Open-market sale President and CEO sold 15,000 shares at $15.06 ($225,890)
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- 4 Grant or award Chief Medical Officer acquired 1,076 shares (grant or award)
- 4 Grant or award Chief Scientific Officer acquired 732 shares (grant or award)
- 4 Grant or award Chief Financial Officer acquired 1,366 shares (grant or award)
- 4 Shares withheld for taxes President and CEO gave up 3,007 shares (to pay taxes)
- SC 13G Stake Amended Statement of Ownership
- SC 13G Stake Amended Statement of Ownership
- 4 Open-market sale Chief Scientific Officer sold 37,164 shares at $12.00 ($445,968)
- 4 Shares withheld for taxes President and CEO gave up 3,007 shares (to pay taxes)
Page 15 of 74 · 1,467 filings